In this study, we used WJ-MSCs as cellular vehicles to deliver CES1 and sTRAIL mRNAs using LNPs combined with CPT-11 to treat lung cancer and lung cancer brain metastases. The gene discussed is CES1; the disease is lung carcinoma.